Format

Send to

Choose Destination
Br J Pharmacol. 2018 Apr;175(7):987-993. doi: 10.1111/bph.14153.

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.

Author information

1
Kings College London, London, UK.
2
University of Nottingham, Nottingham, UK.
3
University of Naples, Naples, Italy.
4
Royal College of Surgeons in Ireland, Dublin, Ireland.
5
Swansea University, Swansea, UK.
6
University of Calgary, Calgary, AB, Canada.
7
The University of Melbourne, Melbourne, VIC, Australia.
8
The Scripps Research Institute, San Diego, CA, USA.
9
University of California, San Diego, CA, USA.
10
Nanjing Medical University, Nanjing, China.
11
University of Liverpool, Liverpool, UK.
12
La Trobe University, Bundoora, VIC, Australia.
13
University College London, London, UK.
14
Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
15
University of Bath, Bath, UK.
16
Queen Mary University of London, London, UK.

Abstract

This article updates the guidance published in 2015 for authors submitting papers to British Journal of Pharmacology (Curtis et al., 2015) and is intended to provide the rubric for peer review. Thus, it is directed towards authors, reviewers and editors. Explanations for many of the requirements were outlined previously and are not restated here. The new guidelines are intended to replace those published previously. The guidelines have been simplified for ease of understanding by authors, to make it more straightforward for peer reviewers to check compliance and to facilitate the curation of the journal's efforts to improve standards.

PMID:
29520785
PMCID:
PMC5843711
DOI:
10.1111/bph.14153
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center